Berberine Vs. Metformin: The Similarities and Differences You Should Know

Diabetes impacts nearly 12% of adults in the United States, and approximately ⅓ of the population is affected by metabolic syndrome. Given the widespread prevalence of these conditions and growing concerns related to pharmaceutical side effects, natural treatment alternatives are gaining popularity.

Berberine, a vibrant yellow, plant-derived compound, has emerged as a promising alternative to metformin, a commonly prescribed medication for diabetes and related metabolic disorders.

This article offers a detailed comparison of berberine and metformin, highlighting their mechanisms of action, efficacy, potential side effects, and implications for patient care.

[signup]

Berberine and Metformin: An Overview

Let's get to know Berberine and Metformin on a deeper level:

Berberine

Berberine is a bioactive compound primarily extracted from the Berberis (barberry) genus of plants. Used traditionally for millennia across different cultures, berberine-rich plants are renowned for their therapeutic properties and applications in a wide range of health issues, including diarrhea, infections, inflammatory diseases, respiratory conditions, and more.

Ongoing clinical studies have emphasized berberine's antioxidant, anti-inflammatory, and immune-modulating properties, demonstrating great potential in regulating blood sugar and lipids, inhibiting cancer cell growth, and supporting a healthy gut microbiome.

Researchers are also investigating its possible role in autoimmune diseases, neurodegenerative disorders, depression, and hormonal imbalances such as polycystic ovary syndrome (PCOS).

Metformin

Metformin is an anti-diabetic drug used as the first-line treatment for type 2 diabetes (T2DM). Beyond its role in T2DM, metformin has numerous off-label indications, including:

Prediabetes
Gestational diabetes
T2DM prevention
Mitigating weight gain caused by antipsychotic drugs
PCOS management

Ongoing research is also exploring metformin’s potential roles in aging, cancer, and neurological health.

Mechanisms of Action

Berberine and Metformin have a lot in common but plenty of differences, too. Here is an overview of both:

Similarities

Both berberine and metformin activate AMP-activated protein kinase (AMPK), an enzyme that regulates cellular energy balance. This has several beneficial effects:

Enhances glucose uptake in the muscles, liver, and fat cells.
Improves insulin sensitivity, aiding glucose entry into the cells and lowering blood sugar levels.
Decreases glucose production in the liver.
Improves the breakdown of fats for energy, a process that occurs in the mitochondria.

Additionally, both compounds reduce intestinal absorption of glucose. Emerging evidence also suggests that both berberine and metformin may benefit the gut microbiome, hormone balance, inflammation, and cancer prevention.

Differences

It is estimated that up to 75% of individuals with T2DM also have hyperlipidemia. While research suggests that metformin therapy alone has positive effects on lipid profiles, some evidence shows that berberine may offer superior results by way of several potential mechanisms:

Increasing LDL receptor (LDLR) activity in the liver to remove LDL (“bad”) cholesterol from the blood.
Decreasing the production of proprotein convertase subtilisin/kexin type 9 (PSCK9), a protein that degrades LDLRs. By reducing PSCK9, berberine helps maintain more active LDLRs, thereby lowering cholesterol levels in the blood.
Preventing excessive fat accumulation in the blood by reducing the activity of lipoprotein lipase, an enzyme that breaks down fats.

Other notable differences include:

Their structure– Whereas berberine is a more complex, plant-derived isoquinoline alkaloid, metformin is a synthetic biguanide compound with a simpler structure.
Metformin exhibits superior oral bioavailability compared to berberine.
While metformin should be avoided in individuals with liver or kidney disease, berberine may exert protective effects on these vital organs.

Efficacy in Managing Type 2 Diabetes and Metabolic Syndrome

Studies comparing berberine and metformin interventions in T2DM patients report no significant differences in their efficacy for reducing fasting glucose, postprandial glucose, or hemoglobin A1c (HbA1c) levels. However, combining the interventions significantly improves these parameters compared to metformin alone while also reducing the incidence of adverse events.

Additionally, berberine may be more effective than metformin in controlling lipids, with short-term studies showing notably lower levels of triglycerides and total cholesterol. Similar effects are observed in PCOS, another metabolic condition.

Recent research indicates that berberine may offer more significant cardiovascular disease risk reduction compared to metformin in this patient population.

This is attributed to its impact on body composition, lipid profiles, and hormonal improvements, including reduced waist size, waist-to-hip ratios, total cholesterol, triglycerides, low-density lipoprotein (LDL), and increased high-density lipoprotein (HDL) and sex hormone binding globulin (SHBG) levels.

Side Effects and Safety Profile

Berberine and Metformin have similar side effects and safety profiles. However, here are the specifics you should know:

The content is presented in a clear and organized format, possibly intended for educational purposes.

Berberine

The most common potential side effects of berberine are gastrointestinal in nature:

Abdominal pain
Constipation
Diarrhea
Nausea
Vomiting

Avoid combining berberine with cyclosporine. Other possible drug interactions include:

Dextromethorphan, a cough medicine
Anti-diabetic drugs, including metformin
Anti-hypertensive drugs, including losartan
Anticoagulants/antiplatelet drugs
Sedative medications, including midazolam and pentobarbital
Tacrolimus, an immunosuppressive drug
Any medication that is a substrate of the following cytochrome P450 enzymes: CYP2C9, CYP2D6, or CYP3A4

Berberine use is contraindicated in:

Pregnant and breastfeeding women, due to berberine’s uterine-stimulating effects.
Infants, as berberine can cause or worsen jaundice and result in kernicterus, a life-threatening condition that causes brain damage.

Metformin

Common side effects of metformin that affect up to 30% of individuals include:

Diarrhea
Nausea
Vomiting

Rare side effects:

Chest discomfort
Headache
Excessive sweating
Hypoglycemia
Weakness
Rhinitis
Vitamin B12 deficiency, particularly with prolonged use
Lactic acidosis occurs in approximately 1 in 30,000 patients

Contraindications to metformin use:

Severe kidney disease
Elevated serum creatinine levels (≥ 1.4 mg/dL in women, ≥ 1.5 mg/dL in men)
Abnormal creatinine clearance
Liver disease
Heart failure
Metabolic acidosis
Hypersensitivity to metformin

Cost, Accessibility, and Patient Preference

Several factors can impact the choice between berberine and metformin. While berberine typically costs less than metformin, insurance coverage for natural alternatives is often lacking, varying based on individual policies.

Additionally, obtaining high-quality berberine supplements can be challenging due to issues like poor bioavailability and consumer confusion when navigating the vast dietary supplement market to find an effective product.

Furthermore, given the often more favorable side effect profiles of natural alternatives like berberine, patients may prefer these options over synthetic treatments like metformin.

Can Berberine and Metformin Be Taken Together?

Evidence supports the safety and efficacy of combining berberine and metformin compared to using either agent alone. It is speculated that their combination may allow for lower dosages of each compound, addressing concerns such as berberine’s poor oral bioavailability and minimizing side effects associated with each substance used separately.

However, comprehensive studies with larger sample sizes and of longer duration are necessary to fully understand their benefits as a combination therapy.

[signup]

Key Takeaways

Berberine and metformin are effective options for managing metabolic conditions like type 2 diabetes, metabolic syndrome, and polycystic ovary syndrome, primarily through their shared mechanism of activating AMPK.

While both interventions demonstrate comparable effects on glucose control, berberine may offer potential advantages in lipid management and cardiovascular risk reduction.

Healthcare providers should stay informed on the latest research and actively engage in open discussions with patients, sharing the benefits and potential risks of each therapeutic option.

By customizing treatment plans according to each individual’s unique needs and preferences, providers can ensure the delivery of safe and optimal care.

Berberine, a vibrant yellow, plant-derived compound, has emerged as a potential alternative to metformin, a commonly prescribed medication for diabetes and related metabolic concerns.

This article offers a detailed comparison of berberine and metformin, highlighting their mechanisms of action, potential benefits, possible side effects, and considerations for patient care.

[signup]

Berberine and Metformin: An Overview

Let's get to know Berberine and Metformin on a deeper level:

It outlines their similarities and differences, specifically in how each substance affects glucose uptake, insulin sensitivity, lipid profiles, and fat metabolism.

Berberine

Berberine is a bioactive compound primarily extracted from the Berberis (barberry) genus of plants. Used traditionally for millennia across different cultures, berberine-rich plants are renowned for their traditional uses in a wide range of health issues, including digestive concerns, infections, inflammatory conditions, respiratory issues, and more.

Ongoing clinical studies have emphasized berberine's antioxidant, anti-inflammatory, and immune-modulating properties, suggesting potential in supporting blood sugar and lipid levels, supporting healthy cell growth, and maintaining a healthy gut microbiome.

Researchers are also investigating its possible role in autoimmune conditions, neurodegenerative disorders, mood support, and hormonal balance such as polycystic ovary syndrome (PCOS).

Metformin

Metformin is an anti-diabetic drug used as the first-line treatment for type 2 diabetes (T2DM). Beyond its role in T2DM, metformin has numerous off-label indications, including:

Prediabetes
Gestational diabetes
T2DM prevention
Mitigating weight gain associated with certain medications
PCOS management

Ongoing research is also exploring metformin’s potential roles in aging, cancer, and neurological health.

Mechanisms of Action

Berberine and Metformin have a lot in common but plenty of differences, too. Here is an overview of both:

Similarities

Both berberine and metformin activate AMP-activated protein kinase (AMPK), an enzyme that helps regulate cellular energy balance. This has several potential benefits:

May enhance glucose uptake in the muscles, liver, and fat cells.
May improve insulin sensitivity, aiding glucose entry into the cells and supporting healthy blood sugar levels.
May decrease glucose production in the liver.
May improve the breakdown of fats for energy, a process that occurs in the mitochondria.

Additionally, both compounds may reduce intestinal absorption of glucose. Emerging evidence also suggests that both berberine and metformin may support the gut microbiome, hormone balance, inflammation, and overall cellular health.

Differences

It is estimated that up to 75% of individuals with T2DM also have hyperlipidemia. While research suggests that metformin therapy alone has positive effects on lipid profiles, some evidence shows that berberine may offer additional support by way of several potential mechanisms:

May increase LDL receptor (LDLR) activity in the liver to help manage LDL (“bad”) cholesterol levels.
May decrease the production of proprotein convertase subtilisin/kexin type 9 (PSCK9), a protein that affects LDLRs. By reducing PSCK9, berberine may help maintain more active LDLRs, thereby supporting healthy cholesterol levels.
May help prevent excessive fat accumulation in the blood by reducing the activity of lipoprotein lipase, an enzyme that breaks down fats.

Other notable differences include:

Their structure– Whereas berberine is a more complex, plant-derived isoquinoline alkaloid, metformin is a synthetic biguanide compound with a simpler structure.
Metformin exhibits superior oral bioavailability compared to berberine.
While metformin should be avoided in individuals with liver or kidney disease, berberine may offer supportive effects on these vital organs.

Efficacy in Managing Type 2 Diabetes and Metabolic Syndrome

Studies comparing berberine and metformin interventions in T2DM patients report no significant differences in their efficacy for supporting healthy fasting glucose, postprandial glucose, or hemoglobin A1c (HbA1c) levels. However, combining the interventions may improve these parameters compared to metformin alone while also reducing the incidence of adverse events.

Additionally, berberine may be more effective than metformin in supporting healthy lipid levels, with short-term studies showing notably lower levels of triglycerides and total cholesterol. Similar effects are observed in PCOS, another metabolic condition.

Recent research indicates that berberine may offer more significant cardiovascular health support compared to metformin in this patient population.

Side Effects and Safety Profile

Berberine and Metformin have similar side effects and safety profiles. However, here are the specifics you should know:

Berberine

The most common potential side effects of berberine are gastrointestinal in nature:

Abdominal pain
Constipation
Diarrhea
Nausea
Vomiting

Avoid combining berberine with cyclosporine. Other possible drug interactions include:

Dextromethorphan, a cough medicine
Anti-diabetic drugs, including metformin
Anti-hypertensive drugs, including losartan
Anticoagulants/antiplatelet drugs
Sedative medications, including midazolam and pentobarbital
Tacrolimus, an immunosuppressive drug
Any medication that is a substrate of the following cytochrome P450 enzymes: CYP2C9, CYP2D6, or CYP3A4

Berberine use is contraindicated in:

Pregnant and breastfeeding women, due to berberine’s uterine-stimulating effects.
Infants, as berberine can cause or worsen jaundice and result in kernicterus, a life-threatening condition that causes brain damage.

Metformin

Common side effects of metformin that affect up to 30% of individuals include:

Diarrhea
Nausea
Vomiting

Rare side effects:

Chest discomfort
Headache
Excessive sweating
Hypoglycemia
Weakness
Rhinitis
Vitamin B12 deficiency, particularly with prolonged use
Lactic acidosis occurs in approximately 1 in 30,000 patients

Contraindications to metformin use:

Severe kidney disease
Elevated serum creatinine levels (≥ 1.4 mg/dL in women, ≥ 1.5 mg/dL in men)
Abnormal creatinine clearance
Liver disease
Heart failure
Metabolic acidosis
Hypersensitivity to metformin

Cost, Accessibility, and Patient Preference

Furthermore, given the often more favorable side effect profiles of natural alternatives like berberine, patients may prefer these options over synthetic treatments like metformin.

Can Berberine and Metformin Be Taken Together?

Evidence supports the safety and potential benefits of combining berberine and metformin compared to using either agent alone. It is speculated that their combination may allow for lower dosages of each compound, addressing concerns such as berberine’s poor oral bioavailability and minimizing side effects associated with each substance used separately.

However, comprehensive studies with larger sample sizes and of longer duration are necessary to fully understand their benefits as a combination therapy.

[signup]

Key Takeaways

Berberine and metformin are options for supporting metabolic health in conditions like type 2 diabetes, metabolic syndrome, and polycystic ovary syndrome, primarily through their shared mechanism of activating AMPK.

While both interventions demonstrate comparable effects on glucose support, berberine may offer potential advantages in lipid management and cardiovascular health support.

Healthcare providers should stay informed on the latest research and actively engage in open discussions with patients, sharing the benefits and potential risks of each therapeutic option.

By customizing treatment plans according to each individual’s unique needs and preferences, providers can ensure the delivery of safe and optimal care.

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (Ed.). (2024, February 6). How to Lower Your Patient’s Triglycerides Using Root Cause Medicine. Rupa Health. https://www.rupahealth.com/post/how-to-lower-your-patients-triglycerides-using-root-cause-medicine

Ataei, S., Prashant Kesharwani, & Amirhossein Sahebkar. (2022). Berberine: Ins and outs of a nature-made PCSK9 inhibitor. EXCLI Journal, 21, 1099–1110. https://doi.org/10.17179/excli2022-5234

Athyros, V. G., Doumas, M., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. (2018). Diabetes and lipid metabolism. Hormones, 17(1), 61–67. https://doi.org/10.1007/s42000-018-0014-8

Bertagna, B. (2024, February 29). The Role of Berberine in Restoring Hormonal Balance in PCOS. Rupa Health. https://www.rupahealth.com/post/the-role-of-berberine-in-restoring-hormonal-balance-in-pcos

Blake, K. (2023, November 14). Integrative Strategies for Neurodegenerative Disease Management. Rupa Health. https://www.rupahealth.com/post/integrative-strategies-for-neurodegenerative-disease-management

Centers for Disease Control and Prevention. (2022, October 25). By the numbers: Diabetes in America. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/php/data-research/index.html#cdc_report_pub_study_section_2-prevalence-of-both-diagnosed-and-undiagnosed-diabetes

Chen, S., Gan, D., Lin, S., Zhong, Y., Chen, M., Zou, X., Shao, Z., & Xiao, G. (2022). Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms. Theranostics, 12(6), 2722–2740. https://doi.org/10.7150/thno.71360

Cleveland Clinic. (2022, November 23). Metabolic Acidosis: Causes, Symptoms, Diagnosis & Treatment. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24492-metabolic-acidosis

Cleveland Clinic. (2023, June 13). Lactic Acidosis: Symptoms, Causes, Treatment & What It Is. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/25066-lactic-acidosis

Cloyd, J. (2023a, March 8). Butyrate 101: Everything You Need to Know About This Short Chain Fatty Acid. Rupa Health. https://www.rupahealth.com/post/butyrate-101-everything-you-need-to-know-about-this-short-chain-fatty-acid

Cloyd, J. (2023b, June 28). Complementary and Integrative Medicine Options for Patients With Liver Disease: Comprehensive Lab Testing, Nutrition, and Supplement Suggestions. Rupa Health. https://www.rupahealth.com/post/a-functional-and-integrative-medicine-approach-to-treating-liver-disease-comprehensive-testing-nutrition-and-treatment-options

Cloyd, J. (2023c, July 20). A functional medicine PCOS protocol: Comprehensive testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-pcos-protocol-comprehensive-testing-therapeutic-diet-and-supplements

Cloyd, J. (2023d, July 28). A Functional Medicine Diarrhea Protocol: Comprehensive Lab Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-diarrhea-protocol-comprehensive-lab-testing-therapeutic-diet-and-supplements

Cloyd, J. (2023e, November 13). The Anti-Inflammatory Lifestyle: From Diet to Mindfulness. Rupa Health. https://www.rupahealth.com/post/the-anti-inflammatory-lifestyle-from-diet-to-mindfulness

Cloyd, J. (2023f, December 19). How to Interpret Your Creatinine Blood Test. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-creatinine-blood-test

Cloyd, J. (2024a, January 2). A Functional Medicine Approach to Prediabetes. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-prediabetes

Cloyd, J. (2024b, January 17). Testing Your Patient's Hemoglobin A1c Levels: A Crucial Tool for Diabetes Management. Rupa Health. https://www.rupahealth.com/post/hba1c-testing-a-crucial-tool-for-diabetes-management-in-functional-medicine

Cloyd, J. (2024c, January 25). What is the Gut Microbiome? Rupa Health. https://www.rupahealth.com/post/what-is-the-gut-microbiome

Cloyd, J. (2024d, March 1). What is Hyperlipidemia? Symptoms, Testing, and Treatments. Rupa Health. https://www.rupahealth.com/post/what-is-hyperlipidemia-symptoms-testing-and-treatments

Cloyd, J. (2024e, March 5). How to Lower LDL Cholesterol Naturally: Evidence-Based Recommendations. Rupa Health. https://www.rupahealth.com/post/how-to-lower-ldl-cholesterol-naturally-evidence-based-recommendations

Cloyd, J. (2024f, March 6). How to Increase HDL Cholesterol: A Root Cause Medicine Approach. Rupa Health. https://www.rupahealth.com/post/how-to-increase-hdl-cholesterol-a-root-cause-medicine-approach

Cloyd, K. (2023, December 19). How to interpret your lipid panel results. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-lipid-panel-results

Corcoran, C., & Jacobs, T. F. (2023, August 17). Metformin. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK518983/

Cross, L. V., & Thomas, J. R. (2020). Safety and Efficacy of Dietary Supplements for Diabetes. Diabetes Spectrum, 34(1), 67–72. https://doi.org/10.2337/ds19-0068

Daglis, S. (2024a, February 21). Decoding the Glucose Level in Your Basic Metabolic Panel. Rupa Health. https://www.rupahealth.com/post/decoding-the-glucose-level-in-your-basic-metabolic-panel

Daglis, S. (2024b, March 12). Emerging Therapies for Lipid Disorders: PCSK9 Inhibitors and Beyond. Rupa Health. https://www.rupahealth.com/post/emerging-therapies-for-lipid-disorders-pcsk9-inhibitors-and-beyond

DeCesaris, L. (2023, July 18). Mitochondria - What They Are, Why We Should Care, and How to Support Them Using Functional Medicine Strategies. Rupa Health. https://www.rupahealth.com/post/mitochondria-what-they-are-why-we-should-care-and-how-to-support-them-using-functional-medicine-strategies

Ezzamouri, B., Rosario, D., Bidkhori, G., Lee, S., Uhlen, M., & Shoaie, S. (2023). Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment. Npj Systems Biology and Applications, 9(1), 1–8. https://doi.org/10.1038/s41540-022-00261-6

Gao, Y., Nie, K., Wang, H., Dong, H., & Tang, Y. (2024). Research progress on antidepressant effects and mechanisms of berberine. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1331440

Garrison, K. (2024, April 5). Luteinizing Hormone Function: Key Player in Reproductive Health. Rupa Health. https://www.rupahealth.com/post/luteinizing-hormone-function-key-player-in-reproductive-health-2

Gillani, S., Ghayedi, N., Roosta, P., Seddigh, P., & Nasiri, O. (2021). Effect of Metformin on Lipid Profiles of Type 2 Diabetes Mellitus: A Metaanalysis of Randomized Controlled Trials. Journal of Pharmacy and Bioallied Sciences, 13(1), 76. https://doi.org/10.4103/jpbs.jpbs_370_20

Guo, H.-H., Shen, H.-R., Wang, L.-L., Luo, Z.-G., Zhang, J.-L., Zhang, H.-J., Gao, T.-L., Han, Y.-X., & Jiang, J.-D. (2023). Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases. Biomedicine & Pharmacotherapy, 163, 114754–114754. https://doi.org/10.1016/j.biopha.2023.114754

Henry, E. (2022, January 4). How To Reverse Weight Gain And Slowed Metabolism. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-slow-metabolism-middle-age

Johns Hopkins Medicine. (n.d.). Rhinitis. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/rhinitis#:~:text=Rhinitis%20is%20when%20a%20reaction

Khakham, C. (2023a, March 28). An integrative medicine approach to kidney disease. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-kidney-disease

Khakham, C. (2023b, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Kim, J., Yang, G., Kim, Y., Kim, J., & Ha, J. (2016). AMPK activators: mechanisms of action and physiological activities. Experimental & Molecular Medicine, 48(4), e224–e224. https://doi.org/10.1038/emm.2016.16

Koppen, L. M., Whitaker, A., Rosene, A., & Beckett, R. D. (2017). Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review. Journal of Evidence-Based Complementary & Alternative Medicine, 22(4), 956–968. https://doi.org/10.1177/2156587216687695

Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69–81. https://doi.org/10.1016/j.jep.2014.09.049

Lin, H., Ao, H., Guo, G., & Liu, M. (2023). The Role and Mechanism of Metformin in Inflammatory Diseases. Journal of Inflammation Research, Volume 16, 5545–5564. https://doi.org/10.2147/jir.s436147

Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023). Promising use of metformin in treating neurological disorders: biomarker-guided therapies. Neural Regeneration Research, 19(5), 1045–1055. https://doi.org/10.4103/1673-5374.385286

Maholy, N. (2023, May 23). A Functional Medicine Treatment Protocol for Metabolic Syndrome: Testing, Nutrition, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-treatment-protocol-for-metabolic-syndrome-testing-nutrition-and-supplements

Manikandan, P., & Nagini, S. (2018). Cytochrome P450 Structure, Function and Clinical Significance: A Review. Current Drug Targets, 19(1). https://doi.org/10.2174/1389450118666170125144557

Mishra, N., Verma, R., & Jadaun, P. (2022). Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study. Cureus, 14(1). https://doi.org/10.7759/cureus.21781

National Center for Complementary and Integrative Health. (2023, June). In the News: Berberine. NCCIH. https://www.nccih.nih.gov/health/in-the-news-berberine

National Heart, Lung, and Blood Institute. (2022a, March 24). Heart Failure - What Is Heart Failure? | NHLBI, NIH. Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/health/heart-failure#:~:text=Heart%20failure%2C%20also%20known%20as

National Heart, Lung, and Blood Institute. (2022b, May 18). Metabolic Syndrome - What Is Metabolic Syndrome? | NHLBI, NIH. Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/health/metabolic-syndrome

National Library of Medicine. (2024, February 22). Berberine: MedlinePlus Supplements. Medlineplus.gov. https://medlineplus.gov/druginfo/natural/1126.html#:~:text=Berberine%20is%20a%20chemical%20found

Neag, M. A., Mocan, A., Echeverría, J., Pop, R. M., Bocsan, C. I., Crişan, G., & Buzoianu, A. D. (2018). Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Frontiers in Pharmacology, 9(557). https://doi.org/10.3389/fphar.2018.00557

Neibling, K. (2023, February 27). Integrative Medicine Treatment for Headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

Och, A., Och, M., Nowak, R., Podgórska, D., & Podgórski, R. (2022). Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules (Basel, Switzerland), 27(4), 1351. https://doi.org/10.3390/molecules27041351

Orbeta, R. (2022, June 6). 10 Type 2 Diabetes Risk Factors You May Not Know About. Rupa Health. https://www.rupahealth.com/post/what-causes-type-2-diabetes

Preston, J. (2022, November 10). What’s The Difference Between Good And Bad Dietary Fat? Rupa Health. https://www.rupahealth.com/post/dietary-fat-the-good-the-bad-and-the-misunderstood

Preston, J. (2023a, July 3). Integrative Medicine and Gestational Diabetes: A Multidisciplinary Approach to Management. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-and-gestational-diabetes-a-multidisciplinary-approach-to-management

Preston, J. (2023b, September 22). Addressing Inflammation in Chronic Diseases: A Functional Medicine Perspective. Rupa Health. https://www.rupahealth.com/post/addressing-inflammation-in-chronic-diseases-a-functional-medicine-perspective

Stanford, J. (2024, March 19). Exploring the Link Between Insulin Resistance and Obesity. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-obesity

Sweetnich, J. (2023a, March 10). Are Your Supplements Making You Constipated? Rupa Health. https://www.rupahealth.com/post/are-your-supplements-making-you-constipated

Sweetnich, J. (2023b, March 13). Are Your Supplements Causing Diarrhea? Rupa Health. https://www.rupahealth.com/post/are-your-supplements-causing-diarrhea

Sweetnich, J. (2023c, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Sweetnich, J. (2023d, April 26). Unlocking the Benefits of Vitamin B12: The Importance of Maintaining Optimal Levels. Rupa Health. https://www.rupahealth.com/post/vitamin-b12-101

Sweetnich, J. (2023e, May 19). Overview of The Liver 101: Top Conditions, Specialty Testing, and Integrative Medicine Treatment Options. Rupa Health. https://www.rupahealth.com/post/overview-liver-101-top-conditions-and-testing

Sweetnich, J. (2023f, June 8). Integrative Treatment Options for The Most Common Pulmonary Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-the-most-common-pulmonary-disorders-specialty-testing-nutrition-supplements

Sweetnich, J. (2023g, June 30). Top 5 Antioxidants That Can Improve Your Health and How To Test Your Patient’s Levels. Rupa Health. https://www.rupahealth.com/post/top-5-antioxidants-to-improve-your-health

Teeter, L. A. (2023, April 25). Complementary and Integrative Medicine for The Treatment of Autoimmune Diseases. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-for-the-treatment-of-autoimmune-diseases

University of Rochester Medical Center. (2024). Sex Hormone Binding Globulin (Blood) - Health Encyclopedia - University of Rochester Medical Center (A. Finke, C. Haldeman-Englert, & T. Novick, Eds.). Www.urmc.rochester.edu. https://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=167&ContentID=shbg_blood

Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022). The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.854885

Wang, H., Zhu, C., Ying, Y., Luo, L., Huang, D., & Luo, Z. (2017). Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget, 9(11), 10135–10146. https://doi.org/10.18632/oncotarget.20807

Wang, L., Liu, D., Wei, G., & Ge, H. (2021). Berberine and Metformin in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis of Randomized Clinical Trials. Health, 13(11), 1314–1329. https://doi.org/10.4236/health.2021.1311096

Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., & Guan, Y. (2012). A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. European Journal of Endocrinology, 166(1), 99–105. https://doi.org/10.1530/EJE-11-0616

Weinberg, J. (2022, December 19). How Short Chain Fatty Acids Affects Our Mood, Digestion, and Metabolism. Rupa Health. https://www.rupahealth.com/post/how-short-chain-fatty-acids-affects-our-mood-digestion-and-metabolism

Weinberg, J. L. (2023, February 21). 5 Lab Test To Run on Your Hypoglycemia Patients. Rupa Health. https://www.rupahealth.com/post/5-lab-test-for-your-hypoglycemia-patients

Weinberg, J. L. (2024, February 2). A Functional Medicine Approach to Jaundice. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-jaundice

Wu, H., Huang, D., Zhou, H., Sima, X., Wu, Z., Sun, Y., Wang, L., Ruan, Y., Wu, Q., Wu, F., She, T., Chu, Y., Huang, Q., Ning, Z., & Zhang, H. (2022). Metformin: A promising drug for human cancers (Review). Oncology Letters, 24(1). https://doi.org/10.3892/ol.2022.13325

Xie, L., Zhang, D., Ma, H., He, H., Xia, Q., Shen, W., Chang, H., Deng, Y., Wu, Q., Cong, J., Wang, C. C., & Wu, X. (2019). The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials. Evidence-Based Complementary and Alternative Medicine, 2019, 1–14. https://doi.org/10.1155/2019/7918631

Xie, W., Su, F., Wang, G., Peng, Z., Xu, Y., Zhang, Y., Xu, N., Hou, K., Hu, Z., Chen, Y., & Chen, R. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 1015045. https://doi.org/10.3389/fphar.2022.1015045

Xiong, R.-G., Huang, S.-Y., Wu, S.-X., Zhou, D.-D., Yang, Z.-J., Saimaiti, A., Zhao, C.-N., Shang, A., Zhang, Y.-J., Gan, R.-Y., & Li, H.-B. (2022). Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules (Basel, Switzerland), 27(14), 4523. https://doi.org/10.3390/molecules27144523

Yang, J., Yin, J., Gao, H., Xu, L., Wang, Y., Xu, L., & Li, M. (2012). Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients. Evidence-Based Complementary and Alternative Medicine : ECAM, 2012. https://doi.org/10.1155/2012/363845

Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental, 57(5), 712–717. https://doi.org/10.1016/j.metabol.2008.01.013

Berberine Vs. Metformin: The Similarities and Differences You Should Know

Berberine and Metformin: An Overview

Berberine

Metformin

Mechanisms of Action

Similarities

Differences

Efficacy in Managing Type 2 Diabetes and Metabolic Syndrome

Side Effects and Safety Profile

Berberine

Metformin

Cost, Accessibility, and Patient Preference

Can Berberine and Metformin Be Taken Together?

Key Takeaways

Berberine and Metformin: An Overview

Berberine

Metformin

Mechanisms of Action

Similarities

Differences

Efficacy in Managing Type 2 Diabetes and Metabolic Syndrome

Side Effects and Safety Profile

Berberine

Metformin

Cost, Accessibility, and Patient Preference

Can Berberine and Metformin Be Taken Together?

Key Takeaways

Learn more

Lab Tests in This Article

References

Latest Articles